✦ LIBER ✦

Breast Cancer in Men—Should Aromatase Inhibitors Become First-Line Hormonal Treatment?

✍ Scribed by Ina C. Nordman; David N. Dalley

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First-line endocrine treatment of breast

✍ Wong, Z-W; Ellis, M J 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 106 KB

Aromatase inhibitors: the new first-line

📂 Article 📅 2000 🏛 Adis International Limited (now part of Wolters Kl ⚖ 148 KB

Systematic review of aromatase inhibitor

✍ Rob Riemsma; C. A. Forbes; A. Kessels; K. Lykopoulos; M. M. Amonkar; D. W. Rea; 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 371 KB

Implications of First-Line Adjuvant Trea

✍ Lisa E. Sokolowicz; William J. Gradishar 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 112 KB

Lapatinib or trastuzumab in combination

✍ Sally Doss; Janet Robertson; Jane Adam 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 42 KB

481 An indirect comparison of aromatase

✍ J. Kleijnen; R. Riemsma; M.M. Amonkar; K. Lykopoulos; J.R. Diaz; C.A. Forbes; D. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 45 KB